Immunosensitization with a Bcl-2 small molecule inhibitor

Cancer immunoediting: from immunosurveillance to tumor escape

2002 • 4,911 citations

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

2005 • 3,292 citations

Cancer immunotherapy: moving beyond current vaccines

2004 • 2,932 citations

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

2003 • 919 citations

The role of BH3-only proteins in the immune system

2005 • 608 citations

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

1996 • 386 citations

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination

2005 • 382 citations

Bim and Bad mediate imatinib-induced killing of Bcr/Abl ⁺ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic

2006 • 331 citations

Enhanced Antigen-Specific Antitumor Immunity with Altered Peptide Ligands that Stabilize the MHC-Peptide-TCR Complex

2000 • 312 citations

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1996 • 206 citations

Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.

1997 • 182 citations

BH3 Mimetic ABT-737 Potentiates TRAIL-Mediated Apoptotic Signaling by Unsequestering Bim and Bak in Human Pancreatic Cancer Cells

2008 • 120 citations

Targeted Therapies to Improve Tumor Immunotherapy

2008 • 114 citations

Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.

2002 • 92 citations

ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis

2008 • 84 citations

Immunosensitization of Tumor Cells to Dendritic Cell-Activated Immune Responses with the Proteasome Inhibitor Bortezomib (PS-341, Velcade)

2006 • 61 citations

Update on Immunotherapy for Melanoma

2006 • 40 citations

Characterization of anti-self CD8 T-cell responses stimulated by recombinant expressing the melanoma antigen TRP-2

2005 • 37 citations

Central Nervous System Tumor Immunity Generated by a Recombinant Listeria monocytogenes Vaccine Targeting Tyrosinase Related Protein-2 and Real-Time Imaging of Intracranial Tumor Burden

2005 • 16 citations

Broad antitumor protection by dendritic cells administered to CD8α knock out mice

2005 • 5 citations